SOOVU LABS INC

SEATTLE, WA · Founded 2014 · Medtech · Private

Wearable medical device that stimulates peripheral C-Tactile fibers and TRPV-1 channels to treat anxiety and stress

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026

Sector: Medtech
Headquarters: SEATTLE, WA
Founded: 2014
Latest Form D: $250K, Dec 2021
Total capital: $6.9M

Federal grants: $385K; 1 award · 2024; Rank in peer group#304 of 445
Private capital raised: $6.5M; 6 Form D · last Dec 2021; 58 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 1; 11 pending · first 2025; Rank in peer group#109 of 445

Capital timeline

Latest events

Jul 2024Federal grantHealth and Human S · Phase I · Treating stress and anxiety in individuals with alcohol use disorder (AUD) using a combination of TRPV-1 channel and C-tactile fiber activation with measurement of oxytocin and cortisol levels$385K
Dec 2021Private capital raisedForm D · SEC · 6th filing$250K
Feb 2021Private capital raisedForm D · SEC · 5th filing$500K
Jan 2020Private capital raisedForm D · SEC · 4th filing$800K
May 2019Private capital raisedForm D · SEC · 3rd filing$1.6M
Jul 2018Private capital raisedForm D · SEC · 2nd filing$3.2M
Feb 2018Private capital raisedForm D · SEC · 1st filing$150K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 445 peers

Line = median

Medtech · Device

Federal grantsBelow median
Granted patents#109 · top 24%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings

Allan StephanExecutive Officer, DirectorNamed in SEC Form D filings
Ed YangDirectorNamed in SEC Form D filings
Peter DunbarExecutive Officer, DirectorNamed in SEC Form D filings
Ronald ChwangDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 12

Jul 24, 2025PendingSystems And Methods For Improved Pain Relief From Stimulation Of Thermal FibersUSPTOApplication 19177390
May 13, 2025GrantedSystems And Methods For Improved Pain Relief From Stimulation Of Thermal FibersUSPTOUS 12,296,129
Jul 13, 2023PendingSystems And Methods For Thermal Fiber StimulationUSPTOApplication 17928990

Show all 12 patent records

Systems And Methods For Improved Pain Relief From Stimulation Of Thermal FibersJul 24, 2025 · Application 19177390Pending
Systems And Methods For Improved Pain Relief From Stimulation Of Thermal FibersMay 13, 2025 · US 12,296,129Granted
Systems And Methods For Thermal Fiber StimulationJul 13, 2023 · Application 17928990Pending
Electrical Isolation During Battery Charging Of Wearable DevicesMar 17, 2022 · Application 17309894Pending
Method For Reversible Chemical Modulation Of Neural ActivityMay 20, 2021 · Application 17082303Pending
Apparatus And Method For Using A Portable Thermal Device To Reduce Accommodation Of Nerve ReceptorsMay 20, 2021 · Application 17065817Pending
Modular Stimulus Applicator System And MethodNov 5, 2020 · Application 16802775Pending
Method And System For Modulating Neural ActivityFeb 7, 2019 · Application 16154036Pending
Systems And Methods For Improved Pain Relief Via Thermal Fiber StimulationApplication 63033635Pending
Electrical Isolation During Battery Charging Of Wearable DevicesApplication PCTUS2019068477Pending
Systems And Methods For Improved Pain Relief From Stimulation Of Thermal FibersApplication PCTUS2019021203Pending
Systems And Methods For Improved Pain Relief Via Thermal Fiber StimulationApplication 63093736Pending

AdvancedCPR Solutions LLCSimilar federal contract value in Medtech · null in contracts
GLYSENS, INC.Similar federal contract value in Medtech · null in contracts
AKOYA BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
ZENALUX BIOMEDICAL, INC.Similar federal contract value in Medtech · null in contracts
AIGENE, INC.Similar federal contract value in Medtech · null in contracts
NOCTRIX HEALTH, INCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.